Not waiting anymoreJust did a deep dive into LABS versus some others in this sector over last couple of days. I can no longer rationalize holding this stock. Even if it has a blowout Q1, it won't amount to much of a boost to SP with 404 million shares out. Cronos has fewer shares out (380 million), has the same debt as LABS, and is sitting on $860 million in cash. At under $4 it looks like a much better value to me so I'm out. Good luck to you all, hope LABS works out for you eventually.